Amanote Research
Register
Sign In
Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy
Journal of Acquired Immune Deficiency Syndromes
- United States
doi 10.1097/qai.0b013e31815b7dba
Full Text
Open PDF
Abstract
Available in
full text
Categories
Infectious Diseases
Pharmacology
Date
December 1, 2007
Authors
Unknown
Publisher
Ovid Technologies (Wolters Kluwer Health)
Related search
Cytomegalovirus Retinitis After the Initiation of Highly Active Antiretroviral Therapy: A 2 Year Prospective Study
British Journal of Ophthalmology
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Progressive Neuropsychiatric Problems Following Institution of Highly Active Antiretroviral Therapy
Sexually Transmitted Infections
Dermatology
Infectious Diseases
Cost-Effectiveness of Highly Active Antiretroviral Therapy in South Africa
PLoS Medicine
Biochemistry
Biotechnology
Molecular Biology
Cell Biology
Medicine
Risk Factors for Blastocystis Infection in HIV/AIDS Patients With Highly Active Antiretroviral Therapy in Southwest China
Infectious Diseases of Poverty
Medicine
Environmental
Public Health
Infectious Diseases
Occupational Health
Sclerosing Cholangitis by Cytomegalovirus in Highly Active Antiretroviral Therapy Era
Revista Espanola de Enfermedades Digestivas
Medicine
Gastroenterology
Relapses of CMV Retinitis After 2 Years of Highly Active Antiretroviral Therapy
British Journal of Ophthalmology
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Effect of HIV Infection and Highly Active Antiretroviral Therapy on Hearing Function
JAMA Otolaryngology - Head and Neck Surgery
Medicine
Otorhinolaryngology
Surgery
Highly Active Antiretroviral Therapy and Hospital Readmission: Comparison of a Matched Cohort
BMC Infectious Diseases
Infectious Diseases
Early Initiation of Antiretroviral Therapy: Debate Over?
The Lancet Infectious Diseases
Infectious Diseases
